Comparison of Hepatic 2D Sandwich Cultures and 3D Spheroids for Long-term Toxicity Applications: A Multicenter Study

Cited by (329)

Items 101–200 of 329

1. Circadian regulation of liver metabolism: experimental approaches in human, rodent, and cellular models
   Lorna J. Daniels, Danielle Kay, Thomas Marjot, Leanne Hodson, David William Ray · 2023 · American Journal of Physiology-Cell Physiology
2. The role of DMPK science in improving pharmaceutical research and development efficiency
   Kit‐Kay Mak, Ola Epemolu, Mallikarjuna Rao Pichika · 2021 · Drug Discovery Today
3. Enhanced in vitro virus expression using 3-dimensional cell culture spheroids for infection
   Alfredo Rosellini, Giulia Freer, Paola Quaranta, Veronica Dovere, Melissa Menichini, Fabrizio Maggi, Paola Mazzetti, Mauro Pistello · 2018 · Journal of Virological Methods
4. The application of omics-based human liver platforms for investigating the mechanism of drug-induced hepatotoxicity in vitro
   Jian Jiang, C. Pieterman, Gökhan Ertaylan, Ralf Peeters, Theo M. C. M. de Kok · 2019 · Archives of Toxicology
5. Evaluation of a Three-Dimensional Primary Human Hepatocyte Spheroid Model: Adoption and Industrialization for the Enhanced Detection of Drug-Induced Liver Injury
   Christopher A. Schofield, Tracy M. Walker, Maxine A. Taylor, Metul Patel, Denise F. Vlachou, Justyna M. Macina, Martin Vidgeon-Hart, Ann Williams, Paul McGill, Carla F. Newman et al. · 2021 · Chemical Research in Toxicology
6. Human iPSC-derived hepatocytes in 2D and 3D suspension culture for cryopreservation and in vitro toxicity studies
   Saskia Altmaier, Ina Meiser, Emilie Lemesre, Benjamin Chanrion, Rachel Steeg, Lidia Elena Leonte, Bjørn Holst, Boye Schnack Nielsen, Christian Clausen, Katharina Schmidt et al. · 2022 · Reproductive Toxicology
7. Evolution of Electrospinning in Liver Tissue Engineering
   Ashwini Vasudevan, Dinesh Mani Tripathi, Subramanian Sundarrajan, Jayarama Reddy Venugopal, Seeram Ramakrishna, Savneet Kaur · 2022 · Biomimetics
8. Developing Liver Microphysiological Systems for Biomedical Applications
   Wang, Jinglin, Wu, Xiangyi, Zhao, Junqi, Ren, Haozhen, Zhao, Yuanjin · 2024 · Advanced Healthcare Materials
9. Conditions for maintenance of hepatocyte differentiation and function in 3D cultures
   Niklas Handin, Evgeniya Mickols, Magnus Ölander, Jakob Rudfeldt, Kristin Blom, Frida Nyberg, Wojciech Senkowski, Jozef Urdzik, Varun Maturi, Mårten Fryknäs et al. · 2021 · iScience
10. State-of-the-art advancements in Liver-on-a-chip (LOC): Integrated biosensors for LOC
    Min Liu, Yuting Xiang, Yuqi Yang, Xingyu Long, Zuoxiu Xiao, Yayun Nan, Yitian Jiang, Yige Qiu, Qiong Huang, Kelong Ai · 2022 · Biosensors and Bioelectronics
11. RGD density along with substrate stiffness regulate hPSC hepatocyte functionality through YAP signalling
    Samuel J.I. Blackford, Tracy T. L. Yu, Michael D. A. Norman, Adam M. Syanda, Michail Manolakakis, Dariusz Lachowski, Ziqian Yan, Yunzhe Guo, Elena Garitta, Federica Riccio et al. · 2022 · Biomaterials
12. Translating in vitro to in vivo and animal to human
    Thomas Steger‐Hartmann, Marian Raschke · 2020 · Current Opinion in Toxicology
13. Toxicogenomics of drug induced liver injury – from mechanistic understanding to early prediction.
    Volker Martin Lauschke · 2021 · Drug Metabolism Reviews
14. Liver Organoids: Updates on Disease Modeling and Biomedical Applications
    Carmen Caiazza, Silvia Parisi, Massimiliano Caiazzo · 2021 · Biology
15. Long-term maintenance of functional primary human hepatocytes in 3D gelatin matrices produced by solution blow spinning
    Mariliis Klaas, Kaidi Möll, Kristina Mäemets‐Allas, Mart Loog, Martin Järvekülg, Viljar Jaks · 2021 · Scientific Reports
16. Analysis of reproducibility and robustness of OrganoPlate® 2-lane 96, a liver microphysiological system for studies of pharmacokinetics and toxicological assessment of drugs
    Yuki Kato, Alicia Y. Lim, Courtney Sakolish, Alan Valdiviezo, Haley L. Moyer, Philip G. Hewitt, Piyush Bajaj, Gang Han, Ivan Rusyn · 2022 · Toxicology in Vitro
17. Construction of functional biliary epithelial branched networks with predefined geometry using digital light stereolithography
    Elsa Mazari‐Arrighi, Dmitry Ayollo, Wissam Farhat, Auriane Marret, Emilie Gontran, Pascale Dupuis‐Williams, Jérôme Larghero, François Chatelain, Alexandra Fuchs · 2021 · Biomaterials
18. Identification of environmental chemicals that activate p53 signaling after in vitro metabolic activation
    Masato Ooka, Jinghua Zhao, Pranav Shah, Jameson Travers, Carleen A. Klumpp-Thomas, Xin Xu, Ruili Huang, Stephen Ferguson, Kristine L. Witt, Stephanie L. Smith‐Roe et al. · 2022 · Archives of Toxicology
19. Gaining New Biological and Therapeutic Applications into the Liver with 3D In Vitro Liver Models
    Sang Woo Lee, Da Jung Jung, Gi Seok Jeong · 2020 · Tissue Engineering and Regenerative Medicine
20. Control compounds for preclinical drug-induced liver injury assessment: Consensus-driven systematic review by the ProEuroDILI network
    Antonio Segovia‐Zafra, Marina Villanueva Paz, A.S. Serras, Gonzalo Matilla‐Cabello, Ana Bodoque-García, Daniel Enrique Di Zeo-Sánchez, Hao Niu, Ismael Álvarez‐Álvarez, Laura Sanz‐Villanueva, Sergej Godec et al. · 2024 · Journal of Hepatology
21. Current insights in the complexities underlying drug-induced cholestasis
    Neel Deferm, Tom De Vocht, Bing Qi, Pieter Van Brantegem, Eva Gijbels, Mathieu Vinken, Peter A.M. de Witte, Thomas W. Bouillon, Pieter Annaert · 2019 · Critical Reviews in Toxicology
22. Modelling fatty liver disease with mouse liver-derived multicellular spheroids
    Elise Anne van Os, Laura Cools, Nathalie Eysackers, Karolina Szafranska, Ayla Smout, Stefaan Verhulst, Hendrik Reynaert, Peter McCourt, Inge Mannaerts, Leo A. van Grunsven · 2022 · Biomaterials
23. 3D culture enhances chemoresistance of ALL Jurkat cell line by increasing DDR1 expression
    Jun Guo, Chunting Zhao, Ruyong Yao, Aihua Sui, Lingjie Sun, Xiaodan Liu, Shao-Ling Wu, Zhan Su, Tianlan Li, Shanshan Liu et al. · 2019 · Experimental and Therapeutic Medicine
24. Bioartificial livers: a review of their design and manufacture
    Tuerxun, Kahaer, He, Jianyu, Ibrahim, Irxat, Yusupu, Zainuer, Yasheng, Abudoukeyimu, Xu, Qilin, Tang, Ronghua, Aikebaier, Aizemati, Wu, Yuanquan, Tuerdi, Maimaitituerxun et al. · 2022 · Biofabrication
25. Metabolic dysfunction-associated steatotic liver disease and steatohepatitis-associated hepatocarcinoma preclinical models
    Jack Leslie, Kishore Alagere Krishnamurthy, Indresh K Gopalsamy, Patrícia Inácio, Meritxell Huch, Suchira Gallage, Fiona Oakley, Michele Vacca · 2026 · Nature Reviews Gastroenterology & Hepatology
26. Identification of miR-199a-5p, miR-214-3p and miR-99b-5p as Fibrosis-Specific Extracellular Biomarkers and Promoters of HSC Activation
    Catherine Jane Messner, Saskia Schmidt, Dilek Özkul, Carine Gaiser, Luigi Terracciano, Stephan Krähenbühl, Laura Suter‐Dick · 2021 · International Journal of Molecular Sciences
27. Hepatic bile acid synthesis and secretion: Comparison of in vitro methods
    Véronique M P de Bruijn, Zhenguo Wang, Wouter Bakker, Weijia Zheng, Bart Spee, Hans Bouwmeester · 2022 · Toxicology Letters
28. Inter-individual differences in the susceptibility of primary human hepatocytes towards drug-induced cholestasis are compound and time dependent
    Celine Parmentier, Delilah F. G. Hendriks, Bruno Heyd, Philippe Bachellier, Magnus Ingelman‐Sundberg, Lysiane Richert · 2018 · Toxicology Letters
29. Transporter–enzyme interplay and the hepatic drug clearance: what have we learned so far?
    Ravindra V. Alluri, Rui Li, Manthena V. S. Varma · 2020 · Expert Opinion on Drug Metabolism & Toxicology
30. Assessment of long-term functional maintenance of primary human hepatocytes to predict drug-induced hepatoxicity in vitro
    Yi Chen, Dan Tang, Hongping Wu, Yu‐Ling Wu, Tianjie Yuan, Hongdan Zhang, Yingfu Jiao, Weifeng Yu, He‐Xin Yan · 2021 · Archives of Toxicology
31. In vitro cell-based models of drug-induced hepatotoxicity screening: progress and limitation
    Maryam Mirahmad, Reyhaneh Sabourian, Mohammad Reza Mahdavi, Bagher A. Larijani, Maliheh Safavi · 2022 · Drug Metabolism Reviews
32. Tacrine First-Phase Biotransformation and Associated Hepatotoxicity: A Possible Way to Avoid Quinone Methide Formation
    Martin Novák, Marie Vajrychová, Stefania Koutsilieri, Despoina-Christina Sismanoglou, Tereza Kobrlová, Lukáš Prchal, Barbora Svobodová, Jan Korábečný, Tomáš Zárybnický, Lucie Raisová Stuchlíková et al. · 2023 · ACS Chemical Biology
33. Recent advances in the development of in vitro liver models for hepatotoxicity testing
    Siming Lu, Jingwei Zhang, Sha Lin, Danfeng Zheng, Yan Shen, Jiale Qin, Yang Yang Li, Shuqi Wang · 2021 · Bio-Design and Manufacturing
34. Integrating in vitro testing and physiologically-based pharmacokinetic (PBPK) modelling for chemical liver toxicity assessment—A case study of troglitazone
    Lin Chen Yu, Hequn Li, Chi Zhang, Qiang Zhang, Jiabin Guo, Jin Li, Haitao Yuan, Lizhong Li, Paul Lawford Carmichael, Shuangqing Peng · 2019 · Environmental Toxicology and Pharmacology
35. Continual proteomic divergence of HepG2 cells as a consequence of long-term spheroid culture
    Andrea Antonio Ellero, Iman van den Bout, Maré Vlok, Duncan Cromarty, Tracey Hurrell · 2021 · Scientific Reports
36. Complex in vitro models positioned for impact to drug testing in pharma: a review
    Serah Kang, Eugene C. Chen, Helen Cifuentes, Julia Y. Co, Gabrielle Cole, Jessica C. Graham, Isaac Hsia, Tomomi Kiyota, Jessica A. Klein, Katharina T. Kroll et al. · 2024 · Biofabrication
37. Development of a device useful to reproducibly produce large quantities of viable and uniform stem cell spheroids with controlled diameters
    Monize Caiado Decarli, Mateus Vidigal de Castro, Júlia A. Nogueira, Mariana Harue Taniguchi Nagahara, Cecília Buzatto Westin, Alexandre Leite Rodrigues de Oliveira, Jorge Vicente L. da Silva, Lorenzo Moroni, Carlos Mota, Ângela Maria Moraes · 2022 · Biomaterials Advances
38. Primary Human Hepatocyte Spheroids as Tools to Study the Hepatotoxic Potential of Non-Pharmaceutical Chemicals
    Vânia Vilas‐Boas, Eva Gijbels, Kaat Leroy, Alanah Pieters, Audrey Baze, Celine Parmentier, Mathieu Vinken · 2021 · International Journal of Molecular Sciences
39. Long‐term maintenance of functional primary human hepatocytes using small molecules
    Takeshi Katsuda, Masaki Kawamata, Ayako Inoue, Tomoko Yamaguchi, Maki Abe, Takahiro Ochiya · 2019 · FEBS Letters
40. Gelatin-Based Hybrid Hydrogel Scaffolds: Toward Physicochemical Liver Mimicry
    Nathan Carpentier, Louis Van der Meeren, André G. Skirtach, Lindsey Devisscher, Hans Van Vlierberghe, Peter Dubruel, Sandra Van Vlierberghe · 2022 · Biomacromolecules
41. Perspective on the Application of Microphysiological Systems to Drug Transporter Studies
    Pedro Caetano-Pinto, Simone H. Stahl · 2018 · Drug Metabolism and Disposition
42. Emerging Three-Dimensional Hepatic Models in Relation to Traditional Two-Dimensional In Vitro Assays for Evaluating Drug Metabolism and Hepatoxicity
    Erin Milner, Michael Ainsworth, Matthew McDonough, Benjamin D. Stevens, Johannah Buehrer, Richard Delzell, Cameron Wilson, Jason C. Barnhill · 2020 · Medicine in Drug Discovery
43. Pre-clinical 2D and 3D toxicity response to a panel of nanomaterials; comparative assessment of NBM-induced liver toxicity
    Melissa Anne Tutty, Gabriele Vella, Adriele Prina‐Mello · 2022 · Drug Delivery and Translational Research
44. Sequential drug delivery for liver diseases
    Xiaozhong Huang, Fan Lee, Yao Teng, Corey Bryen Lingam, Zijian Chen, Min Sun, Ziwei Song, Gowri Manohari Balachander, Hwa Liang Leo, Qiongyu Guo et al. · 2019 · Advanced Drug Delivery Reviews
45. A new cell-sized support for 3D cell cultures based on recombinant spider silk fibers
    Dganit Stern-Tal, Shmulik Ittah, Ella Sklan · 2021 · Journal of Biomaterials Applications
46. Optimization of 3D hydrogel microenvironment for enhanced hepatic functionality of primary human hepatocytes
    Ho‐Joon Lee, Jiwon Ahn, Cho‐Rock Jung, Ye Sul Jeung, Hyun‐Soo Cho, Myung Jin Son, Kyung‐Sook Chung · 2020 · Biotechnology and Bioengineering
47. Metabolomics analysis of the 3D L-02 cell cultures revealing the key role of metabolism of amino acids in ameliorating hepatotoxicity of perfluorooctanoic acid
    Ruijia Zhang, Wenhua Lu, Yao Yao, Lanyin Tu, Tiantian Yu, Tiangang Luan, Baowei Chen · 2021 · The Science of The Total Environment
48. From NAFLD to MAFLD: Aligning Translational In Vitro Research to Clinical Insights
    Gatzios, Alexandra, Rombaut, Matthias, Buyl, Karolien, De Kock, Joery, Rodrigues, Robim M., Rogiers, Vera, Vanhaecke, Tamara, Boeckmans, Joost · 2022 · Biomedicines
49. Liver regeneration biology: Implications for liver tumour therapies
    Christopher Hadjittofi, Michael Feretis, Jack L. Martin, Simon Harper, Emmanuel Huguet · 2021 · World Journal of Clinical Oncology
50. Artificial Cells and HepG2 Cells in 3D‐Bioprinted Arrangements
    Isabella Nymann Westensee, Lars J. M. M. Paffen, Stefan Pendlmayr, Paula De Dios Andres, Miguel A. Ramos‐Docampo, Brigitte Städler · 2024 · Advanced Healthcare Materials
51. Mapping Interindividual Variability of Toxicodynamics Using High-Throughput Transcriptomics and Primary Human Hepatocytes from Fifty Donors
    Marije Niemeijer, Witold Więcek, Shuai Fu, Suzanna Huppelschoten, Peter Bouwman, Audrey Baze, Celine Parmentier, Lysiane Richert, Richard S. Paules, Frédéric Y. Bois et al. · 2024 · Environmental Health Perspectives
52. In vitro hepatic 3D cell models and their application in genetic toxicology: A systematic review
    Martina Štampar, Bojana Žegura · 2024 · Mutation Research/Genetic Toxicology and Environmental Mutagenesis
53. Poly (ethyl 2-cyanoacrylate) nanoparticles (PECA-NPs) as possible agents in tumor treatment
    Antonella Obinu, Giovanna Rassu, Paola Corona, Marcello Maestri, Federica Riva, Dalila Miele, Paolo Giunchedi, Elisabetta Gavini · 2019 · Colloids and Surfaces B Biointerfaces
54. Fabrication and evaluation of modified poly(ethylene terephthalate) microfibrous scaffolds for hepatocyte growth and functionality maintenance
    Wei Liu, Mi Zhang, Miaomiao Zhou, Ce Gu, Zhaoyang Ye, Yan Xiao, Yan Zhou, Meidong Lang, Wen‐Song Tan · 2019 · Materials Science and Engineering C
55. Latest impact of engineered human liver platforms on drug development
    Chase P. Monckton, Grace E. Brown, Salman R. Khetani · 2021 · APL Bioengineering
56. Comparative Study between the 3D‐Liver Spheroid Models Developed from HepG2 and Immortalized Hepatocyte‐Like Cells with Primary Hepatic Stellate Coculture for Drug Metabolism Analysis and Anticancer Drug Screening
    Arunsajee Sae‐be, Teerawat Wiwatpanit, Thaveechai Varatthan, Thanaphon Namporn, Sasiwat Laungkulldej, Ratthiya Thiabma, Atchara Jaiboonma, Khanit Sa‐ngiamsuntorn, Daniel S. Elson, Alexandra E. Porter et al. · 2022 · Advanced Therapeutics
57. Biomaterials for on-chip organ systems
    Shabir Hassan, Marcel Alexander Heinrich, Berivan Çeçen, Jai Prakash, Yu Shrike Zhang · 2020 · Elsevier eBooks
58. Epithelial Cells in 2D and 3D Cultures Exhibit Large Differences in Higher-Order Genomic Interactions
    Xin Liu, Qiu Sun, Qi Wang, Chuansheng Hu, Xuecheng Chen, Hua Li, Daniel Mark Czajkowsky, Zhifeng Shao · 2021 · Genomics Proteomics & Bioinformatics
59. Rapid changes in chromatin structure during dedifferentiation of primary hepatocytes in vitro
    Seirup, Morten, Sengupta, Srikumar, Swanson, Scott, McIntosh, Brian E., Collins, Mike, Chu, Li-Fang, Cheng, Zhang, Gorkin, David U., Duffin, Bret, Bolin, Jennifer M. et al. · 2022 · Genomics
60. Human Liver Spheroids in Chemically Defined Conditions for Studies of Gene–drug, Drug–Drug and Disease–Drug Interactions
    Magnus Ingelman‐Sundberg, Volker Martin Lauschke · 2018 · Pharmacogenomics
61. Evaluation of Drug Biliary Excretion Using Sandwich-Cultured Human Hepatocytes
    Olivier Fardel, A Moreau, Marc Le Vée, Claire Denizot, Yannick Parmentier · 2018 · European Journal of Drug Metabolism and Pharmacokinetics
62. Towards a tiered test strategy for plant protection products to address mixture toxicity by alternative approaches in human health assessment
    Denise Bloch, Philip Marx‐Stoelting, Sabine Martin · 2020 · Pest Management Science
63. Hepatotoxicity of Copper Sulfide Nanoparticles Towards Hepatocyte Spheroids Using A Novel Multi-Concave Agarose Chip Method
    Tianyan Jiang, Haoxiang Guo, Yanan Xia, Yun Liu, Dandan Chen, Guibin Pang, Yahui Feng, Huan Yu, Yanxian Wu, Shaodian Zhang et al. · 2021 · Nanomedicine
64. Functional Proliferating Human Hepatocytes: In Vitro Hepatocyte Model for Drug Metabolism, Excretion, and Toxicity
    Shida Qiao, Sisi Feng, Zhitao Wu, Ting He, Chen Ma, Zhaoliang Peng, E. Tian, Guoyu Pan · 2021 · Drug Metabolism and Disposition
65. In vitro modeling of liver fibrosis with 3D co‐culture system using a novel human hepatic stellate cell line
    Ho‐Joon Lee, Seon Ju Mun, Cho‐Rok Jung, Hyun‐Mi Kang, Jae‐Eun Kwon, Jae‐Sung Ryu, Hyo‐Suk Ahn, Ok‐Seon Kwon, Jiwon Ahn, Kyung-Sik Moon et al. · 2023 · Biotechnology and Bioengineering
66. Slc7a11 stimulates glutathione synthesis to preserve fatty acid metabolism in primary hepatocytes
    Y Liu, Kaimin Wu, Yinkun Fu, Wenyan Li, Xu-Yun Zhao · 2023 · Redox Report
67. Oxidative-stress and long-term hepatotoxicity: comparative study in Upcyte human hepatocytes and hepaRG cells
    María Teresa Donato, Núria Jiménez, María Pelechá-Salvador, Laia Tolosa · 2022 · Archives of Toxicology
68. Establishment of Sandwich Cultures of Primary Human Hepatocytes
    Eva Gijbels, Tamara Vanhaecke, Mathieu Vinken · 2019 · Methods in molecular biology
69. Characterization of primary mouse hepatocyte spheroids as a model system to support investigations of drug-induced liver injury
    Manisha Nautiyal, Rani J. Qasem, John K. Fallon, Kristina Wolf, Jingli Liu, Darlene Dixon, Philip C. Smith, Merrie Mosedale · 2020 · Toxicology in Vitro
70. New frontiers in anti-cancer drug testing: The need for a relevant In vitro testing model
    Anu Varshini A M, Usha Nandhini S, Vivek Kumar, T. Thangam, Krupakar Parthasarathy · 2024 · NAM journal.
71. Microphysiological systems as an emerging in vitro approach for the evaluation of drug absorption, distribution, metabolism, and excretion and toxicity
    Shivangi Shrimali, Dongying Li, Bridgett Knox, Weida Tong, Baitang Ning · 2025 · Drug Metabolism and Disposition
72. Human Liver Microphysiological System for Assessing Drug-Induced Liver Toxicity In Vitro
    Ovidiu Novac, Raul Silva, Lucy-May Young, Kim Lachani, David J. Hughes, Tomasz M. Kostrzewski · 2022 · Journal of Visualized Experiments
73. Human Liver Organoid Models for Assessment of Drug Toxicity at the Preclinical Stage
    Mustafa Karabicici, Soheil Akbari, Özge Ertem, Mukaddes Gümüştekin, Esra Erdal · 2023 · Endocrine Metabolic & Immune Disorders - Drug Targets
74. Comparative analysis of YAP/TEAD inhibitors in 2D and 3D cultures of primary human hepatocytes reveals a novel non-canonical mechanism of CYP induction
    Nuria Oliva‐Vilarnau, Sabine U. Vorrink, Florian Büttner, Timo Heinrich, Janike Sensbach, Isabel Koscielski, Dirk Wienke, Carl Petersson, Dominique Perrin, Volker Martin Lauschke · 2023 · Biochemical Pharmacology
75. In Situ Self-Assembling Liver Spheroids with Synthetic Nanoscaffolds for Preclinical Drug Screening Applications
    Lina Wu, Driton Vllasaliu, Qi Cui, Bahijja Tolulope Raimi‐Abraham · 2024 · ACS Applied Materials & Interfaces
76. Impact of enniatins and beauvericin on lipid metabolism: Insights from a 3D HepaRG spheroid model
    Qiao Wang, Yan Li, Peihao Hu, Yutao Zhang, Yan Liu, Qing Yang, Lin Sen Xu, Zhiyong Gong, Jiangke Yang, Wenguang Sun et al. · 2024 · Environment International
77. Chemical‐based primary human hepatocyte monolayer culture for the study of drug metabolism and hepatotoxicity: Comparison with the spheroid model
    Yixiang Zhong, Jun Sang Yu, Xiaoqiong Wang, Bert Binas, Hye Hyun Yoo · 2021 · The FASEB Journal
78. Current Research Trends in the Application of In Vitro Three-Dimensional Models of Liver Cells
    Chawon Yun, Sou Hyun Kim, Young‐Suk Jung · 2022 · Pharmaceutics
79. Molecular mechanisms of transcription factor mediated cell reprogramming: conversion of liver to pancreas
    Sebastian L. Wild, David Tosh · 2021 · Biochemical Society Transactions
80. Bioengineered Liver Models for Investigating Disease Pathogenesis and Regenerative Medicine
    David A. Kukla, Salman R. Khetani · 2021 · Seminars in Liver Disease
81. Cerebral Organoids Maintain the Expression of Neural Stem Cell-Associated Glycoepitopes and Extracellular Matrix
    Lars Roll, Katrin Lessmann, Oliver Brüstle, Andréas Faissner · 2022 · Cells
82. Three-Dimensional Spheroids for Cancer Research
    Melissa Anne Tutty, Adriele Prina‐Mello · 2023 · Methods in molecular biology
83. Bioengineering liver microtissues for modeling non-alcoholic fatty liver disease
    Negar Aasadollahei, Niloufar Rezaei, Reihaneh Golroo, Tarun Agarwal, Massoud Vosough, Abbas Piryaei · 2023 · EXCLI journal
84. Microphysiological Models for Mechanistic-Based Prediction of Idiosyncratic DILI
    Sydney Stern, Hongbing Wang, Nakissa K. Sadrieh · 2023 · Cells
85. New in vitro screening system to detect drug-induced liver injury using a culture plate with low drug sorption and high oxygen permeability
    Akinori Takemura, Sanae Ishii, Yugo Ikeyama, Katsuhiro Esashika, Jun Takahashi, Kousei Ito · 2023 · Drug Metabolism and Pharmacokinetics
86. Advances, challenges and future applications of liver organoids in experimental regenerative medicine
    Da Gong, Jiaye Mo, Mei Zhai, Fulin Zhou, Guo‐Cai Wang, Shaohua Ma, Xiaoyong Dai, Xuesong Deng · 2025 · Frontiers in Medicine
87. An in vivo mimetic liver-lobule-chip (LLoC) for stem cell maturation, and zonation of hepatocyte-like cells on chip
    Philip Dalsbecker, Siiri Suominen, Muhammad Asim Faridi, Reza Mahdavi, Julia Johansson, Charlotte Hamngren Blomqvist, Mattias Goksör, Katriina Aalto‐Setälä, Leena E. Viiri, Caroline B. Adiels · 2025 · Lab on a Chip
88. Bioengineered Liver Cell Models of Hepatotropic Infections
    Francisca Arez, Ana F. Rodrigues, Catarina Brito, Paula M. Alves · 2021 · Viruses
89. Functional Comparison of HepaRG Cells and Primary Human Hepatocytes in Sandwich and Spheroid Culture as Repeated-Exposure Models for Hepatotoxicity
    Jinpeng Li, Raja S. Settivari, Matthew J. LeBaron, Mary Sue Marty · 2019 · Applied In Vitro Toxicology
90. Two-dimensional-cultures of primary human hepatocytes allow efficient HBV infection: Old tricks still work!
    Julie Lucifora, Maud Michelet, Michel L. Rivoire, Ulrike Protzer, David Durantel, Fabien Zoulim · 2020 · Journal of Hepatology
91. Advances in 3D cell culture for liver preclinical studies
    Ting Yao, Yi Zhang, Mengjiao Lv, Guoqing Zang, Soon Seng Ng, Xiaohua Chen · 2021 · Acta Biochimica et Biophysica Sinica
92. Microfluidic gut-axis-on-a-chip models for pharmacokinetic-based disease models
    Raehyun Kim, Jong Hwan Sung · 2024 · Biomicrofluidics
93. Perspective: How complex in vitro models are addressing the challenges of predicting drug-induced liver injury
    K. Taylor, R. Ram, Lorna C. Ewart, Christopher E. Goldring, Giusy Russomanno, Guruprasad Padur Aithal, Tomasz M. Kostrzewski, Caroline Bauch, J. M. Wilkinson, Stephanie Modi et al. · 2025 · Frontiers in Drug Discovery
94. Formation of functional, extended bile canaliculi, and increased bile acid production in sandwich-cultured human cryopreserved hepatocytes using commercially available culture medium
    Shinichiro Horiuchi, Yukie Kuroda, Ryota Oyafuso, Yuji Komizu, Kazuya Maeda, Seiichi Ishida · 2024 · Archives of Toxicology
95. Enhanced hepatotoxicity assessment through encapsulated HepG2 spheroids in gelatin hydrogel matrices: Bridging the gap from 2D to 3D culture
    Se Yeon Park, W. Koh, Hyun Jong Lee · 2024 · European Journal of Pharmaceutics and Biopharmaceutics
96. Evaluation of the Aryl Hydrocarbon Receptor Response in LMH 3D Spheroids
    Tasnia Sharin, Doug Crump, Jason M. O’Brien · 2020 · Environmental Toxicology and Chemistry
97. In vitro 3D liver tumor microenvironment models for immune cell therapy optimization
    Maxine S. Y. Lam, Jose Antonio Reales‐Calderón, Jin Rong Ow, Giulia Adriani, Andrea Pavesi · 2021 · APL Bioengineering
98. In vitro/in silico prediction of drug induced steatosis in relation to oral doses and blood concentrations by the Nile Red assay
    Tim Brecklinghaus, Wiebke Albrecht, Julia Duda, Franziska Kappenberg, Lisa Gründler, Karolina Edlund, Rosemarie Marchan, Ahmed Ghallab, Cristina Cadenas, Adrian Rieck et al. · 2022 · Toxicology Letters
99. HepaRG Cells Adopt Zonal-Like Drug-Metabolizing Phenotypes under Physiologically Relevant Oxygen Tensions and Wnt/β-Catenin Signaling
    Thomas J. DiProspero, Lauren G. Brown, Trevor D. Fachko, Matthew Ryen Lockett · 2022 · Drug Metabolism and Disposition
100. Hepatic spheroid-on-a-chip: Fabrication and characterization of a spheroid-based in vitro model of the human liver for drug screening applications
     Sultan K. Alshmmari, Roa S. Fardous, Zakia Shinwari, Dana Cialla‐May, Jürgen Popp, Qasem Ramadan, Mohammed M. Zourob · 2024 · Biomicrofluidics